<h1 itemprop="aspect"> <strong>MultiHance Side Effects</strong></h1><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/02/84x84xMultiHance1-84x84.jpg,q1df917.pagespeed.ic.f5gNxDAXzM.jpg" class="attachment-84x84 wp-post-image" alt="MultiHance" title="MultiHance"/></div><h1>Severe Side Effects of MultiHance</h1><ul><li><span style="line-height: 13px;">MultiHance may cause <strong>acute kidney failure</strong> in some patients.  </span></li><li><strong>Cardiac Arrythmia</strong> has been reported by some patients who received MultiHance.  This may be potentially fatal depending on the circumstance.  Multihance may cause first degree atrioventricular block which may lead to<strong> heart failure</strong>.</li><li>MultiHance may cause severe <strong>anaphylactic shock </strong>or other allergic reactions.  It may also cause an allergic reaction at the injection site as well as possible necrosis around the surrounding area.</li></ul><h2>Common Side Effects of MultiHance</h2><ul><li><span style="line-height: 13px;">The most common side effects reported include upset stomach and vomiting, loose stools, burning around the injection site, headache, and dizzy spells.</span></li><li>Other side effects include sneezing, stuff nose, rash, swelling, elevated basophil levels in blood, and numbness or tingling in the skin.</li></ul></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for MultiHance </strong></h2><h2>Black Box Warning for MultiHance</h2><ul><li><span style="line-height: 13px;">Gadolinium-based contrast agents such as MultiHance may cause <strong>Nephrogenic Systemic Fibrosis</strong> in patients with compromised kidney function or impaired drug elimination.  This illness is potentially fatal and can affect the skin, eyes, internal organs, and/or joints.  The patient should be tested for kidney problems prior to receiving MultiHance.  </span></li></ul><h2>Other Warnings for MultiHance</h2><ul><li><span style="line-height: 13px;">MultiHance is a <strong>pregnancy category class C</strong> drug and may be harmful to take while pregnant.  The drug may cause fetal malformations and/or fetal death.</span></li><li>Patients with kidney problems should be screened prior to receiving MultiHance.</li><li>Tell your doctor if you are taking medications for cancer including anthracycline and , vinca alkaloid drugs before receiving MultiHance.</li><li>Some patients may be hypersensitive to MulitHance.</li></ul></div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> MultiHance Treatment and Use </strong></h2><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/02/84x84xMultiHance1-84x84.jpg,q1df917.pagespeed.ic.f5gNxDAXzM.jpg" class="attachment-84x84 wp-post-image" alt="MultiHance" title="MultiHance"/></div><p><strong>MultiHance</strong>| Gadobenate Dimeglumine is a gadolinium-based contrast agent.  It is designed to work with an MRI machine to help clearly <strong>visualize lesions and/or abnormal tissue</strong> in the brain and spine.  It is also used to diagnose certain kinds of vascular disease in some patients.  Recently, gadolinium-based contrast agents such as MultiHance and <a href="http://www.bad-drug.net/bad-drug/gadoteridol" target="_blank"> Gadoteridol</a> were issued a <a title="black box warning" href="http://www.bad-drug.net/black-box-warning">black box warning</a> due to<strong> Nephrogenic Systemic Fibrosis</strong>.  MultiHance is marketed by Bracco Diagnostics.</p><h2>What does MultiHance do?</h2><p>When used with a Magnetic Resonance Imaging machine, MultiHance helps to create a magnetic moment which helps visualize the targeted area.</p><h2>Dosage</h2><p>The usual dose for MultiHance is 0.2 mL per kg of body weight intravenously administered for the Central Nervous System.  For renal and aorto-ilio-femoral vessels, the usual dose is 0.1 mL per kg of body weight.  Following administration of MultiHance, a minimum of 5 mL of saline flush should be injected into the patient for CNS and 20 mL for renal and aorto-ilio-femoral vessels.  MultiHance is available as 529 mg per mL single dose vials and various multi-packs.</p><p>&nbsp;</p></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for MultiHance</h2><h2>Brand Name</h2><br/><ul><br/><li><span style="line-height: 13px;">MultiHance</span></li><br/></ul><br/><h2>Generic Name</h2><br/><ul><br/><li><span style="line-height: 13px;">  Gadobenate Dimeglumine</span></li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for MultiHance </strong></h2>